Veerle De Boe
Overview
Explore the profile of Veerle De Boe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adriaenssens M, De Boe V
J Med Case Rep
. 2023 Oct;
17(1):445.
PMID: 37875965
Background: Congenital lower urinary tract obstruction (LUTO) is a rare but significant condition affecting fetal urinary tract development. LUTO has a range of etiologies, with posterior urethral valves (PUV) being...
2.
Buyl K, Vrints M, Fernando R, Desmae T, Van Eeckhoutte T, Jans M, et al.
Eur J Pharmacol
. 2023 Aug;
957:175989.
PMID: 37572939
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is characterized by intrahepatic triglyceride accumulation and can progress to metabolic dysfunction-associated steatohepatitis (MASH) and liver...
3.
Karamaria S, Ranguelov N, Hansen P, De Boe V, Verleyen P, Segers N, et al.
Front Pediatr
. 2022 Apr;
10:862248.
PMID: 35419322
Conclusion: The voiding diary and the questionnaire, as recommended by the ICCS at the screening of treatment-naïve enuretic patients, are considerably inconsistent and have significantly different sensitivities in identifying LUTS...
4.
Braye A, Bohler S, Vloeberghs V, De Boe V, De Schepper J, Gies I, et al.
Reprod Biomed Online
. 2022 Mar;
44(5):889-895.
PMID: 35282994
Research Question: Which early-diagnosed Klinefelter syndrome patients have been offered cryopreservation of testicular tissue as part of fertility preservation before spermatogonial stem cell (SSC) loss? Do these Klinefelter syndrome patients...
5.
Natale A, Boeckmans J, Desmae T, De Boe V, Kock J, Vanhaecke T, et al.
Toxicol Lett
. 2020 Oct;
333:322-323.
PMID: 33059928
No abstract available.
6.
Boeckmans J, Natale A, Rombaut M, Buyl K, Cami B, De Boe V, et al.
Cell Biol Toxicol
. 2020 Jul;
37(2):293-311.
PMID: 32613381
Non-alcoholic steatohepatitis (NASH) is a highly prevalent, chronic liver disease characterized by hepatic lipid accumulation, inflammation, and concomitant fibrosis. Up to date, no anti-NASH drugs have been approved. In this...
7.
Kock J, Rodrigues R, Branson S, Verhoye L, Colemonts-Vroninks H, Rombaut M, et al.
Cells
. 2020 Apr;
9(4).
PMID: 32276503
Human skin-derived precursors (SKP) represent a group of somatic stem/precursor cells that reside in dermal skin throughout life that harbor clinical potential. SKP have a high self-renewal capacity, the ability...
8.
Bosmans I, De Boe V, Wissing K, Vanhoeij M, Jacobs-Tulleneers-Thevissen D
Acta Chir Belg
. 2019 Nov;
121(5):340-345.
PMID: 31690216
Background: Transplant ureter obstruction is an important cause of graft loss after kidney transplantation. Most cases occur early after transplantation and are related to surgical causes or ischaemic strictures. Underlying...
9.
Boeckmans J, Buyl K, Natale A, Vandenbempt V, Branson S, De Boe V, et al.
Data Brief
. 2019 Jul;
25:104093.
PMID: 31294056
The present dataset contains the transcriptomic characterization of a novel model of non-alcoholic steatohepatitis (NASH) as well as its transcriptomics read-outs for the evaluation of elafibranor, a potential anti-NASH compound....
10.
Boeckmans J, Buyl K, Natale A, Vandenbempt V, Branson S, De Boe V, et al.
Pharmacol Res
. 2019 Apr;
144:377-389.
PMID: 31028903
Non-alcoholic steatohepatitis (NASH) is characterized by hepatocellular steatosis with concomitant hepatic inflammation. Despite its pandemic proportions, no anti-NASH drugs have been approved yet. This is partially because drug development is...